Duff Jr M, Howell E
Methods. 2014; 76:51-60.
PMID: 25462561
PMC: 4380819.
DOI: 10.1016/j.ymeth.2014.11.009.
Vorum H, Jorgensen H, Brodersen R
Eur J Clin Pharmacol. 1993; 44(2):157-62.
PMID: 8453960
DOI: 10.1007/BF00315474.
Wanwimolruk S, Birkett D, Brooks P
Clin Pharmacokinet. 1982; 7(1):85-92.
PMID: 7075085
DOI: 10.2165/00003088-198207010-00005.
Trnavska Z, Trnavsky K, Zlnay D
Eur J Clin Pharmacol. 1984; 26(4):457-61.
PMID: 6734706
DOI: 10.1007/BF00542141.
Trnavska Z, Trnavsky K
Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(1):81-5.
PMID: 6493354
DOI: 10.1007/BF00504996.
Protein binding displacement interactions and their clinical importance.
McElnay J, DArcy P
Drugs. 1983; 25(5):495-513.
PMID: 6345130
DOI: 10.2165/00003495-198325050-00003.
Effects of lysosomal collagenolytic enzymes, anti-inflammatory drugs and other substances on some properties of insoluble collagen.
Anderson A
Biochem J. 1969; 113(3):457-63.
PMID: 5807207
PMC: 1184687.
DOI: 10.1042/bj1130457.
Displacement from protein binding of sulphormethoxine by phenylbutazone using in vivo dialysis in rats.
McQueen E
Br J Pharmacol. 1969; 36(1):29-34.
PMID: 5768126
PMC: 1703584.
DOI: 10.1111/j.1476-5381.1969.tb08300.x.
[Changes in the velocity of drug catabolism and their importance in drug therapy].
Kahl G
Klin Wochenschr. 1971; 49(7):384-96.
PMID: 5102481
DOI: 10.1007/BF01484994.
Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
Tillement J, Zini R, Athis P, Vassent G
Eur J Clin Pharmacol. 1974; 7(4):307-13.
PMID: 4850753
DOI: 10.1007/BF00560349.
Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
Tillement J, Mattei C, Zini R
Experientia. 1974; 30(5):460-1.
PMID: 4833656
DOI: 10.1007/BF01926292.
Indomethacin: plasma concentrations and protein binding in man.
HVIDBERG E, LAUSEN H, Jansen J
Eur J Clin Pharmacol. 1972; 4(2):119-24.
PMID: 4655682
DOI: 10.1007/BF00562508.
[Drugs interacting with coumarine oral anticoagulants (author's transl)].
Gugler R, DENGLER H
Klin Wochenschr. 1973; 51(22):1081-90.
PMID: 4593987
DOI: 10.1007/BF01468301.
The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450.
Di Augustine R, Fouts J
Biochem J. 1969; 115(3):547-54.
PMID: 4390924
PMC: 1185136.
DOI: 10.1042/bj1150547.
Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid.
Huthwohl B, Jahnchen E
Naunyn Schmiedebergs Arch Pharmacol. 1972; 273(3):204-12.
PMID: 4261772
DOI: 10.1007/BF00501412.
Species differences in the influence of chlorothiazide on curarization.
Suarez-Kurtz G, Paulo L
Experientia. 1971; 27(5):539-41.
PMID: 4257185
DOI: 10.1007/BF02147587.
Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.
Lin J, Cocchetto D, DUGGAN D
Clin Pharmacokinet. 1987; 12(6):402-32.
PMID: 3301150
DOI: 10.2165/00003088-198712060-00002.
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
Fossella F, Lippman S, Seitz D, Alberts D, Taylor C, Wiltshaw E
Invest New Drugs. 1991; 9(4):357-9.
PMID: 1804813
DOI: 10.1007/BF00183581.
Benzodiazepines: specific competitors for the binding of L-tryptophan to human serum albumin.
Muller W, Wollert U
Naunyn Schmiedebergs Arch Pharmacol. 1975; 288(1):17-27.
PMID: 1161041
DOI: 10.1007/BF00501811.
Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure.
Odar-Cederlof I, Borga O
Eur J Clin Pharmacol. 1976; 10(6):403-5.
PMID: 1001355
DOI: 10.1007/BF00563076.
